CAI Q4 2016 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$77M+17.6% YoY

Gross Profit

$33M42.6% margin

Operating Income

$17M22.4% margin

Net Income

$489,0000.6% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-1.5%

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

-$45M

Stock-Based Comp.

$412,000

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$1.6B

Stockholders' Equity

$458M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$66M	+17.6%
Gross Profit	$33M	$13M	+158.9%
Operating Income	$17M	-$2M	+1114.1%
Net Income	$489,000	-$13M	+103.9%